AbbVie is a US-based global biopharmaceutical research and development company formed in January 2013 as a spin-off from Abbott Laboratories.
AbbVie is led by Richard A. Gonzales, 30, who previously served as executive vice president of Pharmaceuticals and president of Abbott. It was under his strict leadership that AbbVie has reached its current level - it has drugs in its portfolio that can treat many of the most serious diseases.
The company's success is simple - it successfully combines 125 years of experience in creating various drugs, accumulated since the founding of Abbott in 1888, with innovative biotechnology. Today, drugs developed by AbbVie help patients in more than 170 countries around the world and bring the company $18 billion a year.